BioWorld MedTech

Sep. 17, 2010

New ventures: IntriMed aims to address device industry challenges

A contract manufacturing company that believes "good enough" isn't has been created to help medical device makers address the increasing challenges in the industry. (Medical Device Daily) Read More

Analysts have positive outlook for HeartWare's ADVANCE trial

Report from Europe: Medtronic DBS system gets CE mark for epilepsy indication

Washington roundup: FDA includes Maquet's tardy reply to 483 in warning letter

Financings roundup: Cardinal sells last shares of CareFusion for $705.9M

MDD's food for med-tech thought

Agreements/contracts: MDI, Wells Fargo offer new data analysis series

Med-Tech Notes

HIT roundup: Element115 extends FatWire capabilities via acquisition

People in the News

Patent watch: Amedica granted two new patents for TDR technology

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 29, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 29, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...